Sodium zirconium cyclosilicate

(Lokelma®)

Lokelma®

Drug updated on 11/16/2023

Dosage FormSuspension (oral; 5 g, 10 g)
Drug ClassPotassium binders
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for the treatment of hyperkalemia in adults.

Product Monograph / Prescribing Information

Document TitleYearSource
Lokelma (sodium zirconium cyclosilicate) Prescribing Information.2022AstraZeneca Pharmaceuticals LP, Wilmington, DE

Systematic Reviews / Meta-Analyses

Clinical Practice Guidelines

Document TitleYearSource
Clinical practice guidelines: treatment of acute hyperkalaemia in adults.2020The Renal Association